Loading clinical trials...
Loading clinical trials...
Osteoprotegerin (OPG) in Induced Sputum as a Novel Biomarker for COPD
Conditions
Interventions
Induced sputum
Locations
1
United Kingdom
National Heart and Lung Institute
London, United Kingdom
Start Date
January 1, 2008
Primary Completion Date
March 1, 2010
Completion Date
March 1, 2010
Last Updated
July 10, 2019
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Imperial College London
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions